NL-OMON25639
Recruiting
Not Applicable
Title *Vaccinations in Immunocompromised Patients, Rabies Antibody Response after pre exposure prophylaxis - The VIPRAR study
The International Society of Travel Medicine (ISTM)0 sites50 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- The International Society of Travel Medicine (ISTM)
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults aged 18\-70 years old with a chronic inflammatory condition requiring treatment with one of the following drugs: adalimumab, infliximab, etanercept, golimumab, certolizumab, methotrexate, azathioprine, 6\-mercaptopurine, thioguanine, steroids, tacrolimus or mycophenolic acid.
- •Being naïve to rabies vaccines
- •Anticipated travel to a rabies\-endemic country in the future
Exclusion Criteria
- •Diagnosis of one of the following
- •oPrimary immune deficiency disorder
- •oActive malignancy
- •oAnyone who received chemotherapy or anti\-CD20 in the past 2 years.
- •oHemophilic disorder precluding intramuscular vaccination
- •o(Functional) asplenia
- •oAllergy to any of the components of the rabies vaccine.
- •Not able or willing to consent
- •Using other immunosuppressive agents than the mentioned
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Vaccinations in persons with a condition affecting the immune system: paramount and paradox.ImmunocompromisedHIVImmunosuppressive medicationStem cell transplantationOrgan transplantationrheumatic diseasesinflammatory bowel diseaseVaccineVaccinationHepatitis A vaccinePneumococcal vaccineImmunogenicityNL-OMON24856Amsterdam UMC (locatie AMC)570
Recruiting
Not Applicable
Vaccinations in the Immunocompromised population: paramount and paradox.Immunocompromising conditionsimpaired immune system1002766510021879NL-OMON56421Academisch Medisch Centrum980
Active, not recruiting
Phase 1
Immunization of immunosuppressed patients – Knowledge, practices and serological responseImmunoresponse on pneumococcal vaccination of kidney transplant recipients in immunomodulatory therapy or patients with end stage renal disease.MedDRA version: 21.0Level: LLTClassification code 10076412Term: Chronic kidney disease stage 5System Organ Class: 100000004857MedDRA version: 21.1Level: LLTClassification code 10069594Term: Pneumococcal immunizationSystem Organ Class: 100000004865MedDRA version: 20.0Level: LLTClassification code 10023438Term: Kidney transplantSystem Organ Class: 100000004865Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2016-004123-23-DKDepartment of Infectious Diseases, Odense University Hospital200
Active, not recruiting
Phase 1
Vaccination of antibody deficient patients with Prevenar13 - a comparative study between antibody response and cellular immunity.Patients with IgG-deficiencyTherapeutic area: Body processes [G] - Immune system processes [G12]EUCTR2012-004486-41-SEKarolinska University Hospital, Huddinge, Sweden20
Completed
Not Applicable
Covid-19 Vaccination in Patients with Inflammatory Bowel DiseasesInflammatory Bowel DiseasesDRKS00025694Medizinische Hochschule Hannover23